TY - JOUR
T1 - Primary hormone therapy for locally advanced prostate cancer
AU - Swanson, Gregory P.
PY - 2006/5/1
Y1 - 2006/5/1
N2 - Locally advanced prostate cancer is a treatment dilemma. As with prostate cancer in general, there is no clear evidence that aggressive intervention (ie, surgery or radiation) is superior to noninvasive interventions (eg, delayed treatment or androgen ablation). Because patients with locally advanced prostate cancer have a high risk of local and systemic recurrence, there is some argument to proceed with androgen ablation as the sole modality of treatment. The data using this approach are limited, but an understanding of the degree and duration of response is helpful in selecting patients for primary androgen ablation.
AB - Locally advanced prostate cancer is a treatment dilemma. As with prostate cancer in general, there is no clear evidence that aggressive intervention (ie, surgery or radiation) is superior to noninvasive interventions (eg, delayed treatment or androgen ablation). Because patients with locally advanced prostate cancer have a high risk of local and systemic recurrence, there is some argument to proceed with androgen ablation as the sole modality of treatment. The data using this approach are limited, but an understanding of the degree and duration of response is helpful in selecting patients for primary androgen ablation.
UR - http://www.scopus.com/inward/record.url?scp=33750294967&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33750294967&partnerID=8YFLogxK
U2 - 10.1007/s11934-006-0025-x
DO - 10.1007/s11934-006-0025-x
M3 - Review article
C2 - 16630526
AN - SCOPUS:33750294967
VL - 7
SP - 225
EP - 232
JO - Current Urology Reports
JF - Current Urology Reports
SN - 1527-2737
IS - 3
ER -